Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Omnicell (OMCL) over the last 16 years, with Q3 2025 value amounting to $9.8 million.

  • Omnicell's Capital Expenditures rose 997.97% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year increase of 1467.1%. This contributed to the annual value of $36.5 million for FY2024, which is 1208.23% down from last year.
  • As of Q3 2025, Omnicell's Capital Expenditures stood at $9.8 million, which was up 997.97% from $11.8 million recorded in Q2 2025.
  • Omnicell's Capital Expenditures' 5-year high stood at $13.7 million during Q4 2022, with a 5-year trough of $5.1 million in Q1 2021.
  • For the 5-year period, Omnicell's Capital Expenditures averaged around $9.8 million, with its median value being $9.8 million (2025).
  • Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 4044.63% in 2021, then skyrocketed by 12576.14% in 2022.
  • Omnicell's Capital Expenditures (Quarter) stood at $11.1 million in 2021, then increased by 23.48% to $13.7 million in 2022, then tumbled by 33.67% to $9.1 million in 2023, then rose by 0.19% to $9.1 million in 2024, then rose by 7.33% to $9.8 million in 2025.
  • Its Capital Expenditures stands at $9.8 million for Q3 2025, versus $11.8 million for Q2 2025 and $11.2 million for Q1 2025.